IGF1 and Ewing sarcoma: We also noticed that Ewing sarcoma cell lines expressing low levels of IGF1R, such as A673, were less sensitive to JQ1 in comparison to IGF1R-overexpressing lines, underscoring the significance of the IGF1 autocrine mechanism as a key target of BET inhibitors in Ewing sarcoma.